Skip to main content
. 2017 Jul 28;8(37):60875–60891. doi: 10.18632/oncotarget.19650

Figure 4. Comparison of matrix metalloproteinase 9 in patients with KD without (n = 22) and with (n = 9) coronary artery lesion before being treated with intravenous immunoglobulin.

Figure 4

Data are presented as mean ±standard error. *indicates a p < 0.05 between the groups.